251358
Targeting Plasmodium sporozoite-Kupffer cell interactions with a phage display library
Sung-Jae Cha
,
School of Public Health, Department of Molecular Microbiology and Immunology and Malaria Research Institute, Johns Hopkins University, Baltimore, MD
Monique Stins
,
School of Public Health, Department of Molecular Microbiology and Immunology and Malaria Research Institute, Johns Hopkins University, Baltimore, MD
Marcelo Jacobs-Lorena
,
School of Public Health, Department of Molecular Microbiology and Immunology and Malaria Research Institute, Johns Hopkins University, Baltimore, MD
After inoculation by the bite of an infected mosquito, Plasmodium sporozoites enter the blood stream and infect the liver with unique specificity. Previous evidence suggests that specific sporozoite-Kupffer cell interactions are required for liver invasion to occur but the molecular determinants of these interactions are unknown. By use of a phage display library we identified three peptides that bind to the surface of Kupffer cells. Importantly, these peptides strongly inhibited Plasmodium berghei sporozoite invasion of Kupffer cells in vitro and of the mouse liver in vivo. In a separate set of experiments we determined that antibodies against one of the peptides binds to the surface of sporozoites and protects mice from Plasmodium infection. The results suggest that the selected peptides interact with specific Kupffer cell surface receptor(s) and structurally mimic sporozoite ligands of liver invasion. These findings may lead to the development of novel protective vaccines. Role:I designed the project with assistance of my advisor and almost all of the experiments were done by me.
Learning Areas:
Public health or related research
Learning Objectives: Defining the molecular basis for Kupffer cell recognition by the malaria parasite is the main goal of this project. Malaria parasites invade Kupffer cells to initiate vertebrate infection. We show here how to target specific parasite-host cell recognition, which will shed light on the development of a malaria vaccine.
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am a Delta Omega Honor Society member.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|